IL6 and cerebral malaria: As IL-6 is a key mediator of pro-inflammatory signalling pathways, by targeting IL-6, either through inhibition of its production or blockade of its signalling pathways, it may be possible to reduce the overall inflammatory response in cerebral malaria.